GERMANY – EVP leads EUR 5.1m investment into Signature Diagnostics

EVP invested through VRP Venture Capital Rheinland Pfalz GmbH & Co.KG II. KfW, IBG Risikokapitalfonds I GmbH & Co.KG, managed by Goodvent Beteiligungsmanagement GmbH & Co.KG, and the BFB BeteiligungsFonds Brandenburg GmbH, managed by BC Brandenburg Capital GmbH, also participated in the financing alongside existing business angels and strategic investor OncoMethylome Sciences S.A.

Signature Diagnostics is dedicated to the discovery, validation and commercial development of novel diagnostic products that predict outcome and drug response in patients with colorectal cancer and non-small cell lung cancer. The company is based in Potsdam.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• DACH